|
|
Article: Sanofi-aventis Issues Strong Support for Voluntary 'Guiding Principles' on DTC Advertising.
- Article from:
- PR Newswire
- Article date:
- August 2, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BRIDGEWATER, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo Inc. and Aventis Pharmaceuticals Inc., the U.S. pharmaceutical operating entities of the sanofi-aventis Group, are strongly committed to following the voluntary "Guiding Principles" on direct-to-consumer (DTC) advertising developed by the Pharmaceutical Research and Manufacturers of America (PhRMA) and its member companies, including sanofi-aventis.
"We believe that this approach is the most effective way of addressing the concerns expressed by policymakers and the public about this practice," said Timothy Rothwell, President and Chief Executive Officer of sanofi-aventis in the United States.